CENPC
gene geneOn this page
Also known as CENP-Chcp-4MIF2
Summary
CENPC (centromere protein C, HGNC:1854) is a protein-coding gene on chromosome 4q13.2, encoding Centromere protein C (Q03188). Component of the CENPA-NAC (nucleosome-associated) complex, a complex that plays a central role in assembly of kinetochore proteins, mitotic progression and chromosome segregation. It is a selective cancer dependency (DepMap: 86.7% of cell lines).
Centromere protein C 1 is a centromere autoantigen and a component of the inner kinetochore plate. The protein is required for maintaining proper kinetochore size and a timely transition to anaphase. A putative pseudogene exists on chromosome 12.
Source: NCBI Gene 1060 — RefSeq curated summary.
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 170 total
- Cancer dependency (DepMap): dependent in 86.7% of screened cell lines
- MANE Select transcript:
NM_001812
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:1854 |
| Approved symbol | CENPC |
| Name | centromere protein C |
| Location | 4q13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CENP-C, hcp-4, MIF2 |
| Ensembl gene | ENSG00000145241 |
| Ensembl biotype | protein_coding |
| OMIM | 117141 |
| Entrez | 1060 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 4 protein_coding, 3 retained_intron, 3 nonsense_mediated_decay
ENST00000273853, ENST00000506410, ENST00000506882, ENST00000507196, ENST00000510189, ENST00000513216, ENST00000515140, ENST00000910804, ENST00000929364, ENST00000960630
RefSeq mRNA: 2 — MANE Select: NM_001812
NM_001362481, NM_001812
CCDS: CCDS47063
Canonical transcript exons
ENST00000273853 — 19 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001156505 | 67468762 | 67472675 |
| ENSE00002036687 | 67545338 | 67545503 |
| ENSE00003481382 | 67519217 | 67519502 |
| ENSE00003489010 | 67506788 | 67506934 |
| ENSE00003497249 | 67518156 | 67518368 |
| ENSE00003497771 | 67530815 | 67530914 |
| ENSE00003505673 | 67512402 | 67512569 |
| ENSE00003510849 | 67495159 | 67495212 |
| ENSE00003544191 | 67508814 | 67509105 |
| ENSE00003549647 | 67539840 | 67539934 |
| ENSE00003556321 | 67493884 | 67493988 |
| ENSE00003570959 | 67514074 | 67514687 |
| ENSE00003591694 | 67540980 | 67541050 |
| ENSE00003595330 | 67489967 | 67490121 |
| ENSE00003603092 | 67505205 | 67505284 |
| ENSE00003604070 | 67474888 | 67474978 |
| ENSE00003608882 | 67492869 | 67492997 |
| ENSE00003641200 | 67544149 | 67544195 |
| ENSE00003691778 | 67492180 | 67492275 |
Expression profiles
Bgee: expression breadth ubiquitous, 146 present calls, max score 96.48.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.1847 / max 108.5483, expressed in 1117 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 52309 | 16.0948 | 1707 |
| 52308 | 7.8926 | 1586 |
| 52310 | 2.3479 | 957 |
| 52311 | 0.8367 | 451 |
Top tissues by expression
157 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| calcaneal tendon | UBERON:0003701 | 96.48 | gold quality |
| sural nerve | UBERON:0015488 | 94.07 | gold quality |
| corpus callosum | UBERON:0002336 | 92.50 | gold quality |
| bone marrow cell | CL:0002092 | 92.27 | gold quality |
| bone marrow | UBERON:0002371 | 92.11 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 91.26 | gold quality |
| tonsil | UBERON:0002372 | 90.59 | gold quality |
| body of pancreas | UBERON:0001150 | 88.98 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.58 | gold quality |
| ventricular zone | UBERON:0003053 | 88.01 | gold quality |
| adrenal tissue | UBERON:0018303 | 87.29 | gold quality |
| lymph node | UBERON:0000029 | 86.33 | gold quality |
| left ovary | UBERON:0002119 | 86.33 | gold quality |
| colonic epithelium | UBERON:0000397 | 86.32 | gold quality |
| pancreas | UBERON:0001264 | 86.08 | gold quality |
| ovary | UBERON:0000992 | 85.84 | gold quality |
| endometrium | UBERON:0001295 | 85.71 | gold quality |
| tibial nerve | UBERON:0001323 | 84.56 | gold quality |
| uterine cervix | UBERON:0000002 | 84.48 | gold quality |
| rectum | UBERON:0001052 | 84.10 | gold quality |
| vagina | UBERON:0000996 | 84.07 | gold quality |
| right ovary | UBERON:0002118 | 83.94 | gold quality |
| minor salivary gland | UBERON:0001830 | 83.81 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 83.80 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 83.67 | gold quality |
| gall bladder | UBERON:0002110 | 83.60 | gold quality |
| uterus | UBERON:0000995 | 83.50 | gold quality |
| thyroid gland | UBERON:0002046 | 83.40 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 83.36 | gold quality |
| duodenum | UBERON:0002114 | 83.05 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 8.35 |
Regulation
Is transcription factor: no
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 86.7% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 29)
- CENP-C may target the centromere by establishing multiple contacts with both the DNA and protein constituents of the kinetochore (PMID:12490152)
- the interaction between CENP-B and CENP-C may be involved in the correct assembly of CENP-C on alphoid DNA (PMID:14612452)
- CENPC target sites that can be sumoylated by SUMO-2 were shown to be equally susceptible to SUMO-1 attachments which include specific sites on SUMO-2 itself, Ubc9, and the recombinant CENP-C fragments (PMID:15272016)
- a functional interplay between the chromosomal passenger complex and CENP-C. (PMID:17287400)
- Using protein truncation and in vitro mutagenesis, we have identified the nucleolar localization sequences on CENPC1,and evidence shows that CENPC1 is an RNA-associating protein that binds alpha-satellite RNA by an in vitro binding assay. (PMID:17623812)
- CENP-C and CENP-H co-localize to the CENP-A chromatin domain. (PMID:17651496)
- DNMT3B interacts with CENP-C to modulate DNA methylation and the histone code at centromere. (PMID:19482874)
- C-terminal domain of CENP-C displays multiple and critical functions for mammalian centromere formation (PMID:19503796)
- Direct binding of Cenp-C to the Mis12 complex joins the inner and outer kinetochore. (PMID:21353556)
- CENP-C works as an important factor for centromeric M18BP1 recruitment (PMID:22540025)
- The CENP-A/histone H3.3 nucleosome forms an unexpectedly stable structure and allows the binding of the essential centromeric protein, CENP-C, which is ectopically mislocalized in the chromosomes of CENP-A overexpressing tumor cells. (PMID:25408271)
- CENP-C recruits the Ndc80 complex through its interactions with KNL1 and the Mis12 complex at kinetochores during chromosome segregation. (PMID:25660545)
- We used a synthetic system to dissect how CenH3(CENP-A) contributes to the accumulation of CENP-C and CENP-T, two key components that are necessary for the formation of functional kinetochores (PMID:25843710)
- CENP-B directly binds both CENP-A’s amino-terminal tail and CENP-C, a key nucleator of kinetochore assembly (PMID:25942623)
- CENP-C affects nucleosome shape and dynamics in a manner analogous to allosteric regulation of enzymes. CENP-C depletion leads to rapid removal of CENP-A from centromeres, indicating their collaboration in maintaining centromere identity. (PMID:25954010)
- HPV18 E7 inhibited the binding of CENP-C to alpha-satellite DNAs. (PMID:25997930)
- CENP-C, a CCAN subunit, is crucial for kinetochore assembly because it links centromeres with the microtubule-binding interface of kinetochores. (PMID:26124289)
- CENP-C and CENP-I are key factors connecting kinetochore to CENP-A assembly. (PMID:26527398)
- A nonhistone centromere protein, CENP-C, binds and reshapes the nucleosome, sliding the DNA gyres back to positions similar to those in canonical nucleosomes containing conventional histone H3. (PMID:26878239)
- Upon cross-linking, the entire CENPA/CENPB/CENPC/CENPT complex is nuclease-protected over an alpha-satellite dimer that comprises the fundamental unit of centromeric chromatin. We conclude that CENPA/CENPC and CENPT pathways for kinetochore assembly are physically integrated over young alpha-satellite dimers. (PMID:27384170)
- Whereas CENP-C recruits a single MIS12:NDC80 complex, the authors show here that CENP-T binds one MIS12:NDC80 and two NDC80 complexes upon phosphorylation by the mitotic CDK1:Cyclin B complex at three distinct CENP-T sites. (PMID:28012276)
- Levels of centromere aberrations increase upon depletion of CENP-A, CENP-C, and CENP-T/W, during replicative senescence, and in cancer cells. (PMID:28167779)
- CENP-C specifically binds alpha satellite non-coding RNAs. (PMID:28787590)
- Collectively, these studies clarify how CENP-N and CENP-C decode and stabilize the non-canonical CENP-A nucleosome to enforce epigenetic centromere specification and kinetochore assembly. (PMID:29280735)
- CENP-N stabilizes CENP-A nucleosomes alone and additively with CENP-C in vitro. However, removal of CENP-C and CENP-N from cells, or mutating CENP-A so that it no longer interacts with CENP-C or CENP-N, had no effect on centromeric CENP-A stability in vivo. Thus, the stability of CENP-A nucleosomes in chromatin does not arise solely from its interactions with CENP-C or CENP-N. (PMID:29343552)
- two key conformational changes within the CENP-A nucleosome upon CENP-C binding, are reported. (PMID:31475439)
- CDK1-mediated CENP-C phosphorylation modulates CENP-A binding and mitotic kinetochore localization (PMID:31676716)
- A genetic memory initiates the epigenetic loop necessary to preserve centromere position. (PMID:32945564)
- The Elusive Structure of Centro-Chromatin: Molecular Order or Dynamic Heterogenetity? (PMID:33065112)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:ch211-161h7.4 | ENSDARG00000087238 |
| mus_musculus | Cenpc1 | ENSMUSG00000029253 |
| rattus_norvegicus | Cenpc | ENSRNOG00000021776 |
Protein
Protein identifiers
Centromere protein C — Q03188 (reviewed: Q03188)
Alternative names: Centromere autoantigen C, Centromere protein C 1, Interphase centromere complex protein 7
All UniProt accessions (3): Q03188, H0Y8J2, H0Y9W1
UniProt curated annotations — full annotation on UniProt →
Function. Component of the CENPA-NAC (nucleosome-associated) complex, a complex that plays a central role in assembly of kinetochore proteins, mitotic progression and chromosome segregation. The CENPA-NAC complex recruits the CENPA-CAD (nucleosome distal) complex and may be involved in incorporation of newly synthesized CENPA into centromeres. CENPC recruits DNA methylation and DNMT3B to both centromeric and pericentromeric satellite repeats and regulates the histone code in these regions.
Subunit / interactions. Oligomer. Component of the CENPA-NAC complex, at least composed of CENPA, CENPC, CENPH, CENPM, CENPN, CENPT and CENPU. The CENPA-NAC complex interacts with the CENPA-CAD complex, composed of CENPI, CENPK, CENPL, CENPO, CENPP, CENPQ, CENPR and CENPS. Binds to DAXX. Interacts with DNMT3B. Interacts directly with CENPA. Identified in a centromere complex containing histones H2A, H2B and H4, and at least CENPA, CENPB, CENPC, CENPT, CENPN, HJURP, SUPT16H, SSRP1 and RSF1. Interacts with MEIKIN.
Subcellular location. Nucleus. Chromosome. Centromere. Kinetochore.
Domain organisation. The MIF2 homology domain II targets centromeres and binds the alpha satellite DNA in vivo. The MIF2 homology domain III can induce CENPC dimerization/oligomerization.
Similarity. Belongs to the CENP-C/MIF2 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q03188-1 | 1 | yes |
| Q03188-2 | 2 |
RefSeq proteins (2): NP_001349410, NP_001803* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR011051 | RmlC_Cupin_sf | Homologous_superfamily |
| IPR014710 | RmlC-like_jellyroll | Homologous_superfamily |
| IPR025974 | Mif2/CENP-C_cupin | Domain |
| IPR028052 | CENP-C_N_dom | Domain |
| IPR028386 | CENP-C/Mif2/cnp3 | Family |
| IPR028931 | CENP-C_mid | Domain |
Pfam: PF11699, PF15620, PF15622
UniProt features (65 total): modified residue 21, cross-link 16, region of interest 8, compositionally biased region 7, short sequence motif 4, splice variant 2, sequence variant 2, strand 2, chain 1, sequence conflict 1, helix 1
Structure
Experimental structures (PDB)
17 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7R5R | ELECTRON MICROSCOPY | 2.44 |
| 7PII | ELECTRON MICROSCOPY | 2.68 |
| 28OP | ELECTRON MICROSCOPY | 2.7 |
| 5LSJ | X-RAY DIFFRACTION | 3.25 |
| 7XHO | ELECTRON MICROSCOPY | 3.29 |
| 6MUP | ELECTRON MICROSCOPY | 3.5 |
| 6SE6 | ELECTRON MICROSCOPY | 3.5 |
| 5LSK | X-RAY DIFFRACTION | 3.5 |
| 9TAW | ELECTRON MICROSCOPY | 3.54 |
| 6MUO | ELECTRON MICROSCOPY | 3.6 |
| 6SEF | ELECTRON MICROSCOPY | 3.7 |
| 7XHN | ELECTRON MICROSCOPY | 3.71 |
| 6SEE | ELECTRON MICROSCOPY | 4.2 |
| 9TAX | ELECTRON MICROSCOPY | 4.5 |
| 7QOO | ELECTRON MICROSCOPY | 4.6 |
| 7YYH | ELECTRON MICROSCOPY | 8.9 |
| 7YWX | ELECTRON MICROSCOPY | 12 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q03188-F1 | 48.33 | 0.08 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (37): 73, 96, 130, 146, 183, 189, 225, 261, 316, 333, 376, 397, 439, 528, 538, 684, 709, 710, 734, 763 …
Function
Pathways and Gene Ontology
Reactome pathways
21 pathways
| ID | Pathway |
|---|---|
| R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal |
| R-HSA-2467813 | Separation of Sister Chromatids |
| R-HSA-2500257 | Resolution of Sister Chromatid Cohesion |
| R-HSA-5663220 | RHO GTPases Activate Formins |
| R-HSA-606279 | Deposition of new CENPA-containing nucleosomes at the centromere |
| R-HSA-68877 | Mitotic Prometaphase |
| R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation |
| R-HSA-141424 | Amplification of signal from the kinetochores |
| R-HSA-162582 | Signal Transduction |
| R-HSA-1640170 | Cell Cycle |
| R-HSA-194315 | Signaling by Rho GTPases |
| R-HSA-195258 | RHO GTPase Effectors |
| R-HSA-2555396 | Mitotic Metaphase and Anaphase |
| R-HSA-68882 | Mitotic Anaphase |
| R-HSA-68886 | M Phase |
| R-HSA-69278 | Cell Cycle, Mitotic |
| R-HSA-69618 | Mitotic Spindle Checkpoint |
| R-HSA-69620 | Cell Cycle Checkpoints |
| R-HSA-73886 | Chromosome Maintenance |
| R-HSA-774815 | Nucleosome assembly |
| R-HSA-9716542 | Signaling by Rho GTPases, Miro GTPases and RHOBTB3 |
MSigDB gene sets: 182 (showing top):
GSE45365_NK_CELL_VS_CD8_TCELL_DN, GOBP_MEIOTIC_CHROMOSOME_SEGREGATION, GOBP_CHROMOSOME_ORGANIZATION, GOBP_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE, DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN, GOBP_CHROMOSOME_LOCALIZATION, DARWICHE_SKIN_TUMOR_PROMOTER_DN, DARWICHE_PAPILLOMA_RISK_LOW_UP, DARWICHE_PAPILLOMA_RISK_HIGH_DN, DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN, chr4q13, PUJANA_CHEK2_PCC_NETWORK, GOBP_ORGANELLE_FISSION, GOBP_MITOTIC_NUCLEAR_DIVISION, GOBP_ORGANELLE_ASSEMBLY
GO Biological Process (6): mitotic cell cycle (GO:0000278), chromosome segregation (GO:0007059), cell division (GO:0051301), attachment of mitotic spindle microtubules to kinetochore (GO:0051315), kinetochore assembly (GO:0051382), spindle attachment to meiosis I kinetochore (GO:0051455)
GO Molecular Function (4): DNA binding (GO:0003677), centromeric DNA binding (GO:0019237), identical protein binding (GO:0042802), protein binding (GO:0005515)
GO Cellular Component (11): kinetochore (GO:0000776), condensed chromosome, centromeric region (GO:0000779), inner kinetochore (GO:0000939), nucleus (GO:0005634), nucleoplasm (GO:0005654), pericentric heterochromatin (GO:0005721), cytosol (GO:0005829), nuclear body (GO:0016604), midbody (GO:0030496), chromosome, centromeric region (GO:0000775), chromosome (GO:0005694)
Reactome top-level categories
Rollup of top-14 pathways:
| Category | Pathways |
|---|---|
| Cell Cycle | 3 |
| Mitotic Prometaphase | 2 |
| M Phase | 2 |
| Amplification of signal from the kinetochores | 1 |
| Mitotic Anaphase | 1 |
| RHO GTPase Effectors | 1 |
| Nucleosome assembly | 1 |
| Mitotic Spindle Checkpoint | 1 |
| Signaling by Rho GTPases, Miro GTPases and RHOBTB3 | 1 |
| Signaling by Rho GTPases | 1 |
| Mitotic Metaphase and Anaphase | 1 |
| Cell Cycle, Mitotic | 1 |
| Cell Cycle Checkpoints | 1 |
| Chromosome Maintenance | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular membraneless organelle | 3 |
| cellular anatomical structure | 3 |
| chromosome, centromeric region | 2 |
| cell cycle | 1 |
| mitotic nuclear division | 1 |
| cell cycle process | 1 |
| cellular process | 1 |
| mitotic metaphase chromosome alignment | 1 |
| attachment of spindle microtubules to kinetochore | 1 |
| mitotic cell cycle process | 1 |
| kinetochore organization | 1 |
| protein-containing complex assembly | 1 |
| membraneless organelle assembly | 1 |
| meiotic metaphase I homologous chromosome alignment | 1 |
| attachment of meiotic spindle microtubules to kinetochore | 1 |
| nucleic acid binding | 1 |
| sequence-specific double-stranded DNA binding | 1 |
| protein binding | 1 |
| binding | 1 |
| condensed chromosome, centromeric region | 1 |
| supramolecular complex | 1 |
| condensed chromosome | 1 |
| kinetochore | 1 |
| protein-containing complex | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| heterochromatin | 1 |
| cytoplasm | 1 |
| nucleoplasm | 1 |
| chromosomal region | 1 |
Protein interactions and networks
STRING
904 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CENPC | CENPA | P49450 | 999 |
| CENPC | CENPH | Q9H3R5 | 995 |
| CENPC | CENPB | P07199 | 993 |
| CENPC | CENPT | Q96BT3 | 993 |
| CENPC | CENPS | Q8N2Z9 | 986 |
| CENPC | CENPN | Q96H22 | 986 |
| CENPC | DNMT3B | Q9UBC3 | 978 |
| CENPC | CENPU | Q71F23 | 970 |
| CENPC | CENPI | Q92674 | 966 |
| CENPC | CENPM | Q9NSP4 | 939 |
| CENPC | CENPW | Q5EE01 | 935 |
| CENPC | CENPL | Q8N0S6 | 928 |
| CENPC | CENPO | Q9BU64 | 922 |
| CENPC | CENPK | Q9BS16 | 917 |
| CENPC | CENPP | Q6IPU0 | 915 |
IntAct
136 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NPM1 | NVL | psi-mi:“MI:0914”(association) | 0.610 |
| CENPC | H1-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MIS12 | SPC24 | psi-mi:“MI:0914”(association) | 0.530 |
| RBM34 | NVL | psi-mi:“MI:0914”(association) | 0.530 |
| RRP8 | NVL | psi-mi:“MI:0914”(association) | 0.530 |
| RPL18 | NOP56 | psi-mi:“MI:0914”(association) | 0.530 |
| CENPC | NDC80 | psi-mi:“MI:0914”(association) | 0.530 |
| MACROH2A2 | PPM1G | psi-mi:“MI:0914”(association) | 0.530 |
| N | RBM47 | psi-mi:“MI:0914”(association) | 0.530 |
| RBM4 | NVL | psi-mi:“MI:0914”(association) | 0.530 |
| NIFK | RSL1D1 | psi-mi:“MI:0914”(association) | 0.530 |
| ABT1 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| CENPH | PSMD11 | psi-mi:“MI:0914”(association) | 0.530 |
| MAGEB2 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| RPL13 | RRP8 | psi-mi:“MI:0914”(association) | 0.530 |
| CENPC | CENPC | psi-mi:“MI:0915”(physical association) | 0.520 |
| CENPC | CENPA | psi-mi:“MI:0915”(physical association) | 0.510 |
| DDX21 | MED19 | psi-mi:“MI:2364”(proximity) | 0.480 |
| CENPC | DAXX | psi-mi:“MI:0915”(physical association) | 0.440 |
BioGRID (146): CENPC (Affinity Capture-MS), CENPC (Affinity Capture-MS), CENPC (Affinity Capture-MS), CENPC (Proximity Label-MS), CENPC (Affinity Capture-MS), CENPC (Affinity Capture-MS), CENPC (Affinity Capture-MS), CENPC (Affinity Capture-MS), CENPC (Affinity Capture-MS), CENPC (Affinity Capture-MS), CENPC (Affinity Capture-MS), CENPC (Proximity Label-MS), CENPC (Affinity Capture-MS), MIS12 (Affinity Capture-MS), DSN1 (Affinity Capture-MS)
ESM2 similar proteins: A1L2H3, A2AKX3, A5D8S0, B0S6S9, D3Z987, E1BC15, O43303, O60673, O95405, P56715, Q03188, Q2M2Z5, Q3MHH3, Q3V089, Q569L8, Q5BQN8, Q5CZC0, Q5DTT3, Q5R9I1, Q5VWN6, Q61493, Q641I1, Q6NS59, Q6NSW3, Q6ZP01, Q6ZU52, Q7TSH4, Q7Z333, Q7Z3T8, Q80U44, Q80U59, Q86UW6, Q86WS4, Q86XD8, Q8IXS0, Q8MJ03, Q8MJ04, Q8MJ06, Q8N1H7, Q8N7Z5
Diamond homologs: P49452, P49453, Q03188
SIGNOR signaling
2 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| CENPC | “up-regulates activity” | “CENP-A nucleosome” | binding |
| CENPC | “form complex” | “CCAN complex” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 133 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Nucleosome assembly | 6 | 33.6× | 3e-07 |
| Amplification of signal from the kinetochores | 10 | 23.2× | 3e-10 |
| Peptide chain elongation | 13 | 19.4× | 6e-12 |
| Viral mRNA Translation | 13 | 19.4× | 6e-12 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | 13 | 19.2× | 6e-12 |
| Mitotic Spindle Checkpoint | 10 | 18.7× | 2e-09 |
| Formation of a pool of free 40S subunits | 14 | 18.4× | 4e-12 |
| Selenocysteine synthesis | 13 | 18.4× | 9e-12 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| cytoplasmic translation | 14 | 22.0× | 2e-12 |
| ribosomal large subunit biogenesis | 5 | 18.8× | 5e-04 |
| chromosome segregation | 12 | 17.7× | 1e-09 |
| ribosomal small subunit biogenesis | 7 | 13.5× | 1e-04 |
| negative regulation of translation | 7 | 11.6× | 2e-04 |
| mitotic spindle organization | 5 | 11.5× | 4e-03 |
| rRNA processing | 9 | 10.8× | 2e-05 |
| translation | 12 | 10.4× | 4e-07 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
170 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 129 |
| Likely benign | 12 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2894 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:67472579:A:AC | donor_gain | 1.0000 |
| 4:67472580:C:CC | donor_gain | 1.0000 |
| 4:67472639:T:A | donor_gain | 1.0000 |
| 4:67489959:GTACT:G | donor_loss | 1.0000 |
| 4:67489961:ACTC:A | donor_loss | 1.0000 |
| 4:67489963:TCACC:T | donor_loss | 1.0000 |
| 4:67489964:CACCA:C | donor_loss | 1.0000 |
| 4:67489965:A:AC | donor_gain | 1.0000 |
| 4:67489966:C:CA | donor_gain | 1.0000 |
| 4:67489966:CCA:C | donor_gain | 1.0000 |
| 4:67490122:C:CC | acceptor_gain | 1.0000 |
| 4:67492847:A:AC | donor_gain | 1.0000 |
| 4:67492868:C:CC | donor_gain | 1.0000 |
| 4:67492892:AT:A | donor_gain | 1.0000 |
| 4:67492893:T:TA | donor_gain | 1.0000 |
| 4:67492944:T:TA | donor_gain | 1.0000 |
| 4:67492999:T:A | acceptor_loss | 1.0000 |
| 4:67493878:TTTTA:T | donor_loss | 1.0000 |
| 4:67493879:TTTA:T | donor_loss | 1.0000 |
| 4:67493880:TTAC:T | donor_loss | 1.0000 |
| 4:67493881:TA:T | donor_loss | 1.0000 |
| 4:67493882:A:T | donor_loss | 1.0000 |
| 4:67493883:C:A | donor_loss | 1.0000 |
| 4:67493894:T:A | donor_gain | 1.0000 |
| 4:67493984:CAATA:C | acceptor_gain | 1.0000 |
| 4:67493985:AATA:A | acceptor_gain | 1.0000 |
| 4:67493986:ATA:A | acceptor_gain | 1.0000 |
| 4:67493987:TA:T | acceptor_gain | 1.0000 |
| 4:67493989:C:CC | acceptor_gain | 1.0000 |
| 4:67495153:TCTTA:T | donor_loss | 1.0000 |
AlphaMissense
6236 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:67472623:A:C | F938L | 0.998 |
| 4:67472623:A:T | F938L | 0.998 |
| 4:67472625:A:G | F938L | 0.998 |
| 4:67472624:A:G | F938S | 0.997 |
| 4:67472671:G:C | N922K | 0.997 |
| 4:67472671:G:T | N922K | 0.997 |
| 4:67474896:A:T | V918D | 0.997 |
| 4:67490022:A:G | L872S | 0.997 |
| 4:67490029:C:A | G870W | 0.997 |
| 4:67472630:A:G | L936P | 0.996 |
| 4:67472653:A:C | N928K | 0.996 |
| 4:67472653:A:T | N928K | 0.996 |
| 4:67474973:A:C | F892L | 0.996 |
| 4:67474973:A:T | F892L | 0.996 |
| 4:67474975:A:G | F892L | 0.996 |
| 4:67474902:A:G | F916S | 0.995 |
| 4:67489997:C:A | K880N | 0.995 |
| 4:67489997:C:G | K880N | 0.995 |
| 4:67489999:T:G | K880Q | 0.995 |
| 4:67490028:C:T | G870E | 0.995 |
| 4:67472611:T:A | K942N | 0.994 |
| 4:67472611:T:G | K942N | 0.994 |
| 4:67472635:A:C | S934R | 0.994 |
| 4:67472635:A:T | S934R | 0.994 |
| 4:67472637:T:G | S934R | 0.994 |
| 4:67474948:A:G | C901R | 0.994 |
| 4:67474953:A:G | L899P | 0.994 |
| 4:67472630:A:T | L936H | 0.993 |
| 4:67490028:C:A | G870V | 0.993 |
| 4:67474901:G:C | F916L | 0.992 |
dbSNP variants (sampled 300 via entrez): RS1000000868 (4:67531786 G>A,C), RS1000007497 (4:67469031 CAT>C), RS1000197376 (4:67484457 T>C), RS1000204883 (4:67529277 G>A), RS1000224111 (4:67491912 G>T), RS1000228827 (4:67525444 C>A,T), RS10002575 (4:67483283 G>A,C), RS10003115 (4:67520510 C>G,T), RS1000311832 (4:67469031 C>A,T), RS1000327847 (4:67541713 G>A), RS10003368 (4:67521343 T>C), RS1000368394 (4:67475439 C>A,T), RS1000427653 (4:67491725 A>G), RS1000436744 (4:67531537 T>C), RS1000506300 (4:67536859 T>C)
Disease associations
OMIM: gene MIM:117141 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000266_10 | Multiple sclerosis (severity) | 4.000000e-06 |
| GCST002826_10 | Urate levels (BMI interaction) | 2.000000e-06 |
| GCST006921_13 | Regular attendance at a pub or social club | 7.000000e-09 |
| GCST008476_34 | Emphysema annual change measurement in smokers (percent low attenuation area) | 9.000000e-06 |
| GCST009028_15 | Adverse response to drug | 5.000000e-07 |
| GCST010988_217 | Adult body size | 4.000000e-08 |
| GCST011122_51 | Walking pace | 4.000000e-08 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0004531 | urate measurement |
| EFO:0009592 | social interaction measurement |
| EFO:0007626 | emphysema imaging measurement |
| EFO:0009658 | adverse effect |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
29 total (human), top 29 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression, decreases methylation | 3 |
| perfluorooctane sulfonic acid | decreases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| FR900359 | affects phosphorylation | 1 |
| TAK-243 | decreases sumoylation | 1 |
| dicrotophos | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | decreases expression, increases abundance | 1 |
| coumarin | increases phosphorylation | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 16-hydroxycleroda-3,13(14)-dien-15,16-olide | decreases expression | 1 |
| Bortezomib | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Arsenic Trioxide | increases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | decreases expression, increases abundance | 1 |
| Caffeine | increases phosphorylation | 1 |
| Clorgyline | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Quercetin | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | affects expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Copper Sulfate | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.